Leukemia’s Wake-Up Call – A Case Report of a Patient’s Journey Authors: Ryon Sam, Ann Maria Pappachan, Jasmine Podimon, Sunil Mathew, Anees Ahammed, Ashna Sara Mathew Published: 2024 ABSTRACT ABSTRACTA 26-year-old male complained of fever, right neck swelling, anorexia, and weight loss for 4 months. The patient noticed a right swelling in the root of the neck that progressed from 1 × 1 cm to 5 × 6 cm. We reported a Kikuchi-like acute lymphoblastic leukemia (ALL) case. Three 3 × 3 cm lymph nodes were found in the right cervical area at IIB and III levels, firm, mobile, and nontender. Petechiae and purpura on the left upper limb, wet purpura on the palate, a positive Hess test, and temperature spikes were present. The patient is responding well to ALL treatment. INTRODUCTION Unregulated growth of atypical, immature lymphocytes and their precursors causes bone marrow and lymphoid organ depletion in acute lymphoblastic leukaemia (ALL), a malignancy of B or T lymphoblasts. Men and whites are more prone to have ALL. Because the tumor replaces the bone marrow, ALL patients commonly experience anemia, thrombocytopenia, and neutropenia. Infections, fatigue, and spontaneous bruising/bleeding may occur. Fever, nocturnal sweats, and unexpected weight loss are common. Up to 50% of patients have hepatosplenomegaly and lymphadenopathy.[12] These are progenitor lymphoid neoplasms according to the WHO 2017 classification. The WHO 2017 classification of precursor lymphoid neoplasms includes B-ALL/LBL (lymphoblastic lymphoma) not otherwise defined (NOS), B-ALL/LBL with recurring genetic anomalies, T-ALL/LBL, and NK-ALL/LBL. This disease is characterized by lymphoblasts. Tiny to medium lymphoblasts have scant cytoplasm, moderately compacted to scattered chromatin, and inconspicuous nucleoli. Lymphoblasts in ALL involve the bone marrow and blood, but in LBL, they affect lymph nodes. ALL is diagnosed when the blast count exceeds 20%. Patients might have nodal or extranodal primary lymph node involvement. ALL and LBL sometimes overlap; therefore, a combination diagnosis is investigated. WHO classifies NK-ALL/LBL as uncertain. It is rare and often diagnosed with T-ALL/LBL. One of the earliest neoplasms to respond to treatment was ALL.[345] We reported a case report of ALL with characteristics similar to those of Kikuchi disease. CASE PRESENTATION A 26-year-old male complained of fever, right neck swelling, anorexia, and weight loss for 4 months. He had low-grade intermittent fever with evening chills and nocturnal sweats. Four months ago, the patient noticed a painless right-sided swelling in the root of neck that progressed from 1 × 1 cm to 5 × 6 cm. He thereafter detected multiple swellings in the right supraclavicular area and axilla, which showed no discoloration or ulceration. He noticed loosening of clothes with loss of appetite and generalized fatigue. He had no cough, throat pain, rhinitis, bone and joint pain, rashes, bleeding symptoms, dysphagia, and dyspnea. He had no recent travel or exposure to animals. He had no known comorbidities or hospitalizations; there was history of treated tuberculosis lymph node in father 6 years back. The patient had a mixed diet, normal sleep, reduced appetite, regular bowel and bladder habits, no addictions, and no high-risk behavior. With these complaints, he visited a head-and-neck surgeon. Central necrosis, lymphadenopathy, and right cervical lymph node stations IIB, III, IV A, IV B, VI A, and VI B were found on the CT head and neck scan. An enlarged right upper jugular lymph node was biopsied. However, his problems persisted and the swellings increased. In the Surgery OPD of a tertiary hospital, he underwent an excision biopsy of the same swelling while awaiting the results. For further therapy, the patient was transferred from Surgery to Medicine. He was pale, moderately built, and well nourished, with BMI 23.3 kg/m2. Three 3 × 3 cm lymph nodes were palpable in the right cervical area at IIB and III levels, firm, mobile, and nontender with pinchable skin and no discoloration. Three 5 × 3 cm right supraclavicular lymph nodes with bosellated surfaces, irregular edges, and matted and firm consistency were present. Two 2 × 2 cm right axillary lymph nodes were firm and palpable. No other lymph nodes were palpable. No ulcers, tonsillar enlargement, purpuric rashes, sternal pain, scalp swelling, or proptosis was present. Vitals showed a pulse rate of 80 beats/minute, 99.9 °F temperature, 110/70 mmHg blood pressure, and 20/minute respiratory rate. Hess test was positive. Systemic examination showed a palpable liver 4 cm below the right costal border, with a firm consistency and a smooth surface, with a liver span of 18 cm. The spleen was palpable beneath the left costal margin. The rest of the systemic examination was within normal limits. The patient was admitted with a differential diagnosis of malignancy (leukemia or lymphoma) or infection (tuberculosis or Kikuchi disease). Blood tests revealed anemia (9.3 g/dl), leukocytosis (13800 cells/mm3), ESR 80 mm/hour, CRP 50.3 mg/dl, thrombocytopenia (20000 L/cumm), and elevated LDH of 1119. The sputum AFB, dengue profile, lepto-PCR, IgM, HIV ELISA, DCT, Widal, TORCH, ANA IFA, and RF tests were all negative. There was no growth in urine or blood cultures. The USG neck revealed several hypoechoic cervical lymph nodes, with intrinsic necrosis. A well-defined hypoechoic area measuring 1.5 × 1.9 cm in the mid supraclavicular area was present, deep to the subcutaneous plane and containing fluid. The axilla was screened and revealed several enlarged axillary nodes, with interior cystic areas (3.2 × 1.8 cm). The ultrasound abdomen revealed grade I-II fatty liver with borderline splenomegaly. The biopsy revealed adipose tissue, a tiny lymph node, and large areas of crushed artefact. Figure 1a shows areas of necrosis (marked by a blue arrow) in the lymph node as well as karryorhectic debris [Figure 1b]. The remaining lymph nodes contain mature cells with attempted follicular formation [Figure 2a]. These morphological characteristics were indicative of necrotizing lymphadenitis (Kikuchi disease). PBS revealed mild normocytic normochromic anemia, mild leucocytosis with relative lymphocytosis containing atypical cells, mild to moderate eosinophilia, and severe thrombocytopenia [Figure 2b]. Histological findings in the lymph node. (a) Areas of necrosis; (b) Karryorhectic debris Histological features of mature lymphocytes and nucleated RBCs. (a) Mature lymphocytes with attempted follicle formation; (b) Nucleated RBCs/100 WBCs (indicated by blue arrows) and polychromatophilic cells (indicated by green arrows) A bone marrow trephine biopsy performed [Figure 3a and b] revealed two fragments of cortical bone with only two small subcortical marrow spaces containing obvious crush artifacts, suggesting an acute leukemic process. Flow cytometry demonstrated 50% blast cells and eosinophilia. Blast cells were MPO-negative. 8nRBCs/100 WBCs were observed. Immunophenotyping revealed blast cells (50%, moderate/dim CD45). CD2 (moderate), CD3 (partial/dim), CD5 (dim-moderate), CD7 (heterogeneous -bright), CD34 (dim-moderate), CD38 (moderate-dim), CD117 (partial/dim), and cytoplasmic CD3 (heterogeneous) were all expressed. The CD1a, CD4, CD8, HLA-DR, and cytoplasmic MPO were all negative. Findings of bone marrow aspirate and trephine biopsy. (a) Bone marrow aspirate; (b) Bone marrow trephine biopsy Based on the foregoing reports, the patient was diagnosed as acute T-lymphoblastic leukemia. The patient is currently receiving therapy for ALL and is responding well. DISCUSSION Morphology, immunophenotyping, and cytogenetic analysis diagnose T-cell ALL, which has substantial prognostic implications for patient management. Recent discoveries include early T-cell precursor acute lymphoblastic leukemia/lymphoma (ETP-ALL), a T-cell ALL subset with a different genetic expression profile and immunophenotype. ETP cells come from immature thymocytes that can become T-cells and myeloid cells, indicating direct hematopoietic stem cell origin. CD82 and CD1a2, but not CD5, and myeloid or stem cell markers are seen in ETP-ALL blasts. ETP-ALL gene expression is similar to normal and myeloid leukemic stem cells but different from non-ETP-ALL. A further entity known as “near” ETP has been described according to CD5 and myeloid antigen expression. ETP-ALL affects 15% of children and 35% of adults with T-cell ALL and is associated with high minimal residual disease after treatment and poor long-term prognosis.[6] Modern immunotherapies use naked antibodies, antibodies conjugated to cytotoxic medicines, and bispecific antibodies that activate T-cells.[2] The immunophenotype must be evaluated to determine the T-cell origin of the tumor. This can be done with immunohistochemistry or flow cytometry. Unlike flow cytometry, immunohistochemistry can evaluate large lymphoid cells without losing them during processing.[7] T-cell antigens are produced but not consistently (CD2+/−, CD3+/−, CD7−/+, CD5+/−).[8] The majority of cases result in the deletion of one or more mature T-cell antigens, such as CD7 or CD5.[9] T-ALL therapy is tailored to the patient’s clinical variant, degree of disease severity, and other considerations. CONCLUSION About 50% of T-cell ALL patients undergoing aggressive treatment are cured. Innovative agents and intensifying protocols in adolescents and young adults should lead to future advancements. Understanding disease pathophysiology helps implement focused therapy for specific illnesses. Conflicts of interest There are no conflicts of interest.